Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Contract Extension

9 Jun 2022 07:00

RNS Number : 2925O
Kanabo Group PLC
09 June 2022
 

 

Kanabo Group Plc.

("Kanabo" or the "Company")

 

Contract Extension

 

The GP Service Extends its Contact with a Major UK Food Retailer

 

Kanabo Group Plc. (LON: KNB), announces an extension to its existing contract between the GP Service and one of the United Kingdom's ("UK") largest group of retail businesses including food retail, wholesale, e-pharmacy, insurance, and legal services.

 

The recently acquired GP Service, originally partnered with the retailer in 2019, for the provision of general medical assistance for its members. The original agreement was limited to the submission of the patient's medical history online where the GP Service doctors would review information provided by the patient and complete the prescription for the retailer to arrange subsequent fulfilment and delivery of any approved medication.

 

Under the new Contract Extension, the GP Service will also now provide live Video Consultation services with prescriptions available for collection through the GP Service partner network of over 4,000 pharmacies across the UK. Users will normally see a doctor and may receive a prescription for collection on the same video call. In addition to prescription services, the GP Service will also provide fit notes and referrals.

 

Consultations will be available between 8am and 8pm, Monday to Sunday, 365 days a year. Consultations are usually available within 30 minutes with approximately 95% of all prescriptions available within 60 minutes of the consultation.

 

Atul Devani, CEO of the GP Service commented: "The extension of this agreement reflects the successful relationship we have had since we began working together in 2019. Our integration with the NHS summary care records ensures our services are both safe & secure and we now look forward to extending our services to include virtual GP consultations with automated digital prescriptions."

 

Kanabo, CEO, Avihu Tamir, said: "I am delighted to see this contract extension with a major retailer in the UK, which goes a long way to validating our rationale for the acquisition earlier this year. The GP Service is an innovative Telemedicine Provider, that forms an integral part of the overall strategy at Kanabo, and I look forward to extending our services in the UK further over the coming months and years."

 

 

For further information, please visit http://www.kanabogroup.com/ or https://www.voxmarkets.co.uk/listings/LON/KNB or contact the following:

 

Kanabo Group Plc

Via Vox Markets

Avihu Tamir, CEO

Peterhouse Capital Ltd (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Lauren Riley

Vox Markets (Investor Relations)

KanaboGroup@voxmarkets.co.uk

Kat Perez

kperez@voxmarkets.co.uk

 

 

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers.

 

It has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFIFEERDIAIIF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.